Global COVID-19 Drug API Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15572502 | Publishing Date : 17-Apr-2020 | No. of pages : 98
Detailed TOC of Global COVID-19 Drug API Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COVID-19 Drug API Revenue
1.4 Market Analysis by Type
1.4.1 Global COVID-19 Drug API Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hydroxychloroquine
1.4.3 Chloroquine Phosphate
1.4.4 Others
1.5 Market by Application
1.5.1 Global COVID-19 Drug API Market Share by Application: 2020 VS 2026
1.5.2 Tablet
1.5.3 Injection
1.6 Coronavirus Disease 2019 (Covid-19): COVID-19 Drug API Industry Impact
1.6.1 How the Covid-19 is Affecting the COVID-19 Drug API Industry
1.6.1.1 COVID-19 Drug API Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and COVID-19 Drug API Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for COVID-19 Drug API Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 COVID-19 Drug API Market Perspective (2015-2026)
2.2 COVID-19 Drug API Growth Trends by Regions
2.2.1 COVID-19 Drug API Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 Drug API Historic Market Share by Regions (2015-2020)
2.2.3 COVID-19 Drug API Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 COVID-19 Drug API Market Growth Strategy
2.3.6 Primary Interviews with Key COVID-19 Drug API Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Drug API Players by Market Size
3.1.1 Global Top COVID-19 Drug API Players by Revenue (2015-2020)
3.1.2 Global COVID-19 Drug API Revenue Market Share by Players (2015-2020)
3.1.3 Global COVID-19 Drug API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global COVID-19 Drug API Market Concentration Ratio
3.2.1 Global COVID-19 Drug API Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by COVID-19 Drug API Revenue in 2019
3.3 COVID-19 Drug API Key Players Head office and Area Served
3.4 Key Players COVID-19 Drug API Product Solution and Service
3.5 Date of Enter into COVID-19 Drug API Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global COVID-19 Drug API Historic Market Size by Type (2015-2020)
4.2 Global COVID-19 Drug API Forecasted Market Size by Type (2021-2026)
5 COVID-19 Drug API Breakdown Data by Application (2015-2026)
5.1 Global COVID-19 Drug API Market Size by Application (2015-2020)
5.2 Global COVID-19 Drug API Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America COVID-19 Drug API Market Size (2015-2020)
6.2 COVID-19 Drug API Key Players in North America (2019-2020)
6.3 North America COVID-19 Drug API Market Size by Type (2015-2020)
6.4 North America COVID-19 Drug API Market Size by Application (2015-2020)
7 Europe
7.1 Europe COVID-19 Drug API Market Size (2015-2020)
7.2 COVID-19 Drug API Key Players in Europe (2019-2020)
7.3 Europe COVID-19 Drug API Market Size by Type (2015-2020)
7.4 Europe COVID-19 Drug API Market Size by Application (2015-2020)
8 China
8.1 China COVID-19 Drug API Market Size (2015-2020)
8.2 COVID-19 Drug API Key Players in China (2019-2020)
8.3 China COVID-19 Drug API Market Size by Type (2015-2020)
8.4 China COVID-19 Drug API Market Size by Application (2015-2020)
9 Japan
9.1 Japan COVID-19 Drug API Market Size (2015-2020)
9.2 COVID-19 Drug API Key Players in Japan (2019-2020)
9.3 Japan COVID-19 Drug API Market Size by Type (2015-2020)
9.4 Japan COVID-19 Drug API Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia COVID-19 Drug API Market Size (2015-2020)
10.2 COVID-19 Drug API Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia COVID-19 Drug API Market Size by Type (2015-2020)
10.4 Southeast Asia COVID-19 Drug API Market Size by Application (2015-2020)
11 India
11.1 India COVID-19 Drug API Market Size (2015-2020)
11.2 COVID-19 Drug API Key Players in India (2019-2020)
11.3 India COVID-19 Drug API Market Size by Type (2015-2020)
11.4 India COVID-19 Drug API Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America COVID-19 Drug API Market Size (2015-2020)
12.2 COVID-19 Drug API Key Players in Central & South America (2019-2020)
12.3 Central & South America COVID-19 Drug API Market Size by Type (2015-2020)
12.4 Central & South America COVID-19 Drug API Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Shanghai Zhongxi Sunve Pharma Co., Ltd.
13.1.1 Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Details
13.1.2 Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview and Its Total Revenue
13.1.3 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Introduction
13.1.4 Shanghai Zhongxi Sunve Pharma Co., Ltd. Revenue in COVID-19 Drug API Business (2015-2020))
13.1.5 Shanghai Zhongxi Sunve Pharma Co., Ltd. Recent Development
13.2 Cinkate
13.2.1 Cinkate Company Details
13.2.2 Cinkate Business Overview and Its Total Revenue
13.2.3 Cinkate COVID-19 Drug API Introduction
13.2.4 Cinkate Revenue in COVID-19 Drug API Business (2015-2020)
13.2.5 Cinkate Recent Development
13.3 Fuan Pharmaceutical Group
13.3.1 Fuan Pharmaceutical Group Company Details
13.3.2 Fuan Pharmaceutical Group Business Overview and Its Total Revenue
13.3.3 Fuan Pharmaceutical Group COVID-19 Drug API Introduction
13.3.4 Fuan Pharmaceutical Group Revenue in COVID-19 Drug API Business (2015-2020)
13.3.5 Fuan Pharmaceutical Group Recent Development
13.4 Wuhan Wuyao Pharmaceutical Co., Ltd
13.4.1 Wuhan Wuyao Pharmaceutical Co., Ltd Company Details
13.4.2 Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview and Its Total Revenue
13.4.3 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Introduction
13.4.4 Wuhan Wuyao Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2015-2020)
13.4.5 Wuhan Wuyao Pharmaceutical Co., Ltd Recent Development
13.5 Shenhua Pharmaceutical Co., Ltd
13.5.1 Shenhua Pharmaceutical Co., Ltd Company Details
13.5.2 Shenhua Pharmaceutical Co., Ltd Business Overview and Its Total Revenue
13.5.3 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Introduction
13.5.4 Shenhua Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2015-2020)
13.5.5 Shenhua Pharmaceutical Co., Ltd Recent Development
13.6 Chongqing Kangle Pharmaceutical Co., Ltd.
13.6.1 Chongqing Kangle Pharmaceutical Co., Ltd. Company Details
13.6.2 Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
13.6.3 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Introduction
13.6.4 Chongqing Kangle Pharmaceutical Co., Ltd. Revenue in COVID-19 Drug API Business (2015-2020)
13.6.5 Chongqing Kangle Pharmaceutical Co., Ltd. Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global COVID-19 Drug API Market Size, Status and Forecast 2020-2026
List of TablesTable 1. COVID-19 Drug API Key Market Segments
Table 2. Key Players Covered: Ranking by COVID-19 Drug API Revenue
Table 3. Ranking of Global Top COVID-19 Drug API Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global COVID-19 Drug API Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hydroxychloroquine
Table 6. Key Players of Chloroquine Phosphate
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four COVID-19 Drug API Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for COVID-19 Drug API Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for COVID-19 Drug API Players to Combat Covid-19 Impact
Table 13. Global COVID-19 Drug API Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global COVID-19 Drug API Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global COVID-19 Drug API Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global COVID-19 Drug API Market Share by Regions (2015-2020)
Table 17. Global COVID-19 Drug API Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global COVID-19 Drug API Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. COVID-19 Drug API Market Growth Strategy
Table 23. Main Points Interviewed from Key COVID-19 Drug API Players
Table 24. Global COVID-19 Drug API Revenue by Players (2015-2020) (Million US$)
Table 25. Global COVID-19 Drug API Market Share by Players (2015-2020)
Table 26. Global Top COVID-19 Drug API Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Drug API as of 2019)
Table 27. Global COVID-19 Drug API by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players COVID-19 Drug API Product Solution and Service
Table 30. Date of Enter into COVID-19 Drug API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 33. Global COVID-19 Drug API Market Size Share by Type (2015-2020)
Table 34. Global COVID-19 Drug API Revenue Market Share by Type (2021-2026)
Table 35. Global COVID-19 Drug API Market Size Share by Application (2015-2020)
Table 36. Global COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 37. Global COVID-19 Drug API Market Size Share by Application (2021-2026)
Table 38. North America Key Players COVID-19 Drug API Revenue (2019-2020) (Million US$)
Table 39. North America Key Players COVID-19 Drug API Market Share (2019-2020)
Table 40. North America COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 41. North America COVID-19 Drug API Market Share by Type (2015-2020)
Table 42. North America COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 43. North America COVID-19 Drug API Market Share by Application (2015-2020)
Table 44. Europe Key Players COVID-19 Drug API Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players COVID-19 Drug API Market Share (2019-2020)
Table 46. Europe COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 47. Europe COVID-19 Drug API Market Share by Type (2015-2020)
Table 48. Europe COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 49. Europe COVID-19 Drug API Market Share by Application (2015-2020)
Table 50. China Key Players COVID-19 Drug API Revenue (2019-2020) (Million US$)
Table 51. China Key Players COVID-19 Drug API Market Share (2019-2020)
Table 52. China COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 53. China COVID-19 Drug API Market Share by Type (2015-2020)
Table 54. China COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 55. China COVID-19 Drug API Market Share by Application (2015-2020)
Table 56. Japan Key Players COVID-19 Drug API Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players COVID-19 Drug API Market Share (2019-2020)
Table 58. Japan COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 59. Japan COVID-19 Drug API Market Share by Type (2015-2020)
Table 60. Japan COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 61. Japan COVID-19 Drug API Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players COVID-19 Drug API Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players COVID-19 Drug API Market Share (2019-2020)
Table 64. Southeast Asia COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia COVID-19 Drug API Market Share by Type (2015-2020)
Table 66. Southeast Asia COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia COVID-19 Drug API Market Share by Application (2015-2020)
Table 68. India Key Players COVID-19 Drug API Revenue (2019-2020) (Million US$)
Table 69. India Key Players COVID-19 Drug API Market Share (2019-2020)
Table 70. India COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 71. India COVID-19 Drug API Market Share by Type (2015-2020)
Table 72. India COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 73. India COVID-19 Drug API Market Share by Application (2015-2020)
Table 74. Central & South America Key Players COVID-19 Drug API Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players COVID-19 Drug API Market Share (2019-2020)
Table 76. Central & South America COVID-19 Drug API Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America COVID-19 Drug API Market Share by Type (2015-2020)
Table 78. Central & South America COVID-19 Drug API Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America COVID-19 Drug API Market Share by Application (2015-2020)
Table 80. Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Details
Table 81. Shanghai Zhongxi Sunve Pharma Co., Ltd. Business Overview
Table 82. Shanghai Zhongxi Sunve Pharma Co., Ltd. Product
Table 83. Shanghai Zhongxi Sunve Pharma Co., Ltd. Revenue in COVID-19 Drug API Business (2015-2020) (Million US$)
Table 84. Shanghai Zhongxi Sunve Pharma Co., Ltd. Recent Development
Table 85. Cinkate Company Details
Table 86. Cinkate Business Overview
Table 87. Cinkate Product
Table 88. Cinkate Revenue in COVID-19 Drug API Business (2015-2020) (Million US$)
Table 89. Cinkate Recent Development
Table 90. Fuan Pharmaceutical Group Company Details
Table 91. Fuan Pharmaceutical Group Business Overview
Table 92. Fuan Pharmaceutical Group Product
Table 93. Fuan Pharmaceutical Group Revenue in COVID-19 Drug API Business (2015-2020) (Million US$)
Table 94. Fuan Pharmaceutical Group Recent Development
Table 95. Wuhan Wuyao Pharmaceutical Co., Ltd Company Details
Table 96. Wuhan Wuyao Pharmaceutical Co., Ltd Business Overview
Table 97. Wuhan Wuyao Pharmaceutical Co., Ltd Product
Table 98. Wuhan Wuyao Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2015-2020) (Million US$)
Table 99. Wuhan Wuyao Pharmaceutical Co., Ltd Recent Development
Table 100. Shenhua Pharmaceutical Co., Ltd Company Details
Table 101. Shenhua Pharmaceutical Co., Ltd Business Overview
Table 102. Shenhua Pharmaceutical Co., Ltd Product
Table 103. Shenhua Pharmaceutical Co., Ltd Revenue in COVID-19 Drug API Business (2015-2020) (Million US$)
Table 104. Shenhua Pharmaceutical Co., Ltd Recent Development
Table 105. Chongqing Kangle Pharmaceutical Co., Ltd. Company Details
Table 106. Chongqing Kangle Pharmaceutical Co., Ltd. Business Overview
Table 107. Chongqing Kangle Pharmaceutical Co., Ltd. Product
Table 108. Chongqing Kangle Pharmaceutical Co., Ltd. Revenue in COVID-19 Drug API Business (2015-2020) (Million US$)
Table 109. Chongqing Kangle Pharmaceutical Co., Ltd. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Drug API Market Share by Type: 2020 VS 2026
Figure 2. Hydroxychloroquine Features
Figure 3. Chloroquine Phosphate Features
Figure 4. Others Features
Figure 5. Global COVID-19 Drug API Market Share by Application: 2020 VS 2026
Figure 6. Tablet Case Studies
Figure 7. Injection Case Studies
Figure 8. COVID-19 Drug API Report Years Considered
Figure 9. Global COVID-19 Drug API Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global COVID-19 Drug API Market Share by Regions: 2020 VS 2026
Figure 11. Global COVID-19 Drug API Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global COVID-19 Drug API Market Share by Players in 2019
Figure 14. Global Top COVID-19 Drug API Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Drug API as of 2019
Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Drug API Revenue in 2019
Figure 16. North America COVID-19 Drug API Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe COVID-19 Drug API Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China COVID-19 Drug API Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan COVID-19 Drug API Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia COVID-19 Drug API Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India COVID-19 Drug API Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America COVID-19 Drug API Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Shanghai Zhongxi Sunve Pharma Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Shanghai Zhongxi Sunve Pharma Co., Ltd. Revenue Growth Rate in COVID-19 Drug API Business (2015-2020)
Figure 25. Cinkate Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Cinkate Revenue Growth Rate in COVID-19 Drug API Business (2015-2020)
Figure 27. Fuan Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Fuan Pharmaceutical Group Revenue Growth Rate in COVID-19 Drug API Business (2015-2020)
Figure 29. Wuhan Wuyao Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Wuhan Wuyao Pharmaceutical Co., Ltd Revenue Growth Rate in COVID-19 Drug API Business (2015-2020)
Figure 31. Shenhua Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Shenhua Pharmaceutical Co., Ltd Revenue Growth Rate in COVID-19 Drug API Business (2015-2020)
Figure 33. Chongqing Kangle Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Chongqing Kangle Pharmaceutical Co., Ltd. Revenue Growth Rate in COVID-19 Drug API Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed
Keyplayers in Global COVID-19 Drug API Market Size, Status and Forecast 2020-2026
Shanghai Zhongxi Sunve Pharma Co., Ltd.Cinkate
Fuan Pharmaceutical Group
Wuhan Wuyao Pharmaceutical Co., Ltd
Shenhua Pharmaceutical Co., Ltd
Chongqing Kangle Pharmaceutical Co., Ltd.